LIPELLA PHARMACEUTICALS INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lipella Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Lipella Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $69.6K, a 55.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $69.6K -$86.9K -55.5% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $92K -$30.6K -24.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $114K -$22.8K -16.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $135K -$15.7K -10.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $156K Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $123K Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $137K Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $151K -$54K -26.4% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $205K Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.